Voyager Therapeutics Q3 EPS $(0.41) Beats $(0.76) Estimate, Sales $20.433M Beat $7.64M Estimate

Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.76) by 46.05 percent. This is a 34.92 percent increase over losses of $(0.63) per share

Benzinga · 11/06/2019 12:27

Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.76) by 46.05 percent. This is a 34.92 percent increase over losses of $(0.63) per share from the same period last year. The company reported quarterly sales of $20.433 million which beat the analyst consensus estimate of $7.64 million by 167.45 percent. This is a 875.79 percent increase over sales of $2.094 million the same period last year.